News from canntab therapeutics limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 01, 2020, 08:30 ET Canntab Begins Delivery of Tablets to MediPharm

TORONTO, Dec. 1, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Oct 26, 2020, 00:53 ET Canntab to Launch in Australia and Participate in Australia's Largest Cannabis Research Study

TORONTO, Oct. 26, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...


Sep 21, 2020, 09:14 ET Canntab Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tablets

TORONTO, Sept. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...


Aug 21, 2020, 08:56 ET Canntab announces planned purchases of cannabis processing equipment and leasehold improvements

TORONTO, Aug. 21, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...


Aug 19, 2020, 07:30 ET Canntab Appoints Larry Latowsky as CEO

TORONTO, Aug. 19, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F) (the "Company" or "Canntab"), the...


Jun 02, 2020, 10:41 ET Canntab and Medipharm Labs Enter Into a Wholesale Tablet Purchase Agreement

TORONTO, June 2, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


May 15, 2020, 07:30 ET Canntab Appoints Joshi Laxminarayan as Chief Scientific Officer

TORONTO, May 15, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


May 11, 2020, 07:30 ET Canntab to Present at the Canaccord Genuity 2020 Virtual Cannabis Conference

TORONTO, May 11, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Mar 16, 2020, 07:30 ET Canntab Closes Final Tranche of Private Placement for Aggregate Proceeds of $3.7m

TORONTO, March 16, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading ...


Mar 06, 2020, 08:00 ET Canntab Announces Replacement of Advisor Warrants and Intention to Appoint Larry Latowsky as Director and Executive Chairman of the Board

TORONTO, March 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Mar 02, 2020, 09:15 ET Canntab Receives Health Canada Licence and Closes $3.08M Offering

Receives its Cannabis Standard Processing & Sales for Medical Purposes Licence Closes first tranche of its non-brokered private placement for gross...


Feb 24, 2020, 07:30 ET Canntab Awarded Health Canada Cannabis Research Licence

TORONTO, Feb. 24, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Feb 06, 2020, 13:38 ET Canntab Announces Non-Brokered Private Placement

TORONTO, Feb. 6, 2020 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN)(OTCQB:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Dec 23, 2019, 02:30 ET Canntab Submits Site Evidence Package to Health Canada to Obtain LP Status

The final step to obtain a licence to process Canntab's cannabis hard pill formulation, at its fully built out Markham, Ontario facility. Retains...


Nov 20, 2019, 12:15 ET Canntab Achieves Key Milestone: Canntab Enters Into Supply & Distribution Agreements With Exactus for the Purchase of Hemp-Derived CBD Oil and the Distribution of Canntab's Hard Pill Formulations in the United States

Canntab will manufacture its hard pill formulations (made from CBD and other hemp derivatives) in a Florida facility operated by Exactus, using...


Oct 08, 2019, 11:29 ET Canntab to utilize the advanced BOSS extraction system from World Class Extractions to further its own extraction capabilities

TORONTO, Oct. 8, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Oct 08, 2019, 07:30 ET Canntab to utilize the advanced BOSS extraction system from Word Class Extractions to further its own extraction capabilities

TORONTO, Oct. 8, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading...


Aug 15, 2019, 07:00 ET Canntab Receives Initial Indication of Patentability for Immediate Release Cannabidiol Formulation

TORONTO, Aug. 15, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the "Company" or "Canntab"), the leading ...


Jul 31, 2019, 06:30 ET Canntab provides corporate update

Commercial batch manufacturing of oil-filled gel capsules to begin in Cobourg, leading to a Health Canada request for authorization to begin full...


May 30, 2019, 11:54 ET Canntab signs term sheet with Heritage for processing hemp for sale of CBD filled gelcaps

- Canntab Makes Progress Towards Becoming Revenue-Generating in 2019 - TORONTO, May 30, 2019 /PRNewswire/ - Canntab Therapeutics Limited...


May 21, 2019, 07:30 ET Canntab Receives Cultivation Licence for Industrial Hemp

Enables Canntab to Leverage Properties in Saskatchewan and Ontario to Cultivate High Quality Hemp for the Extraction of Cannabidiol (CBD)...


May 01, 2019, 08:30 ET Canntab Therapeutics Now Trading on the OTCQX Best Market

Canntab upgrades to the OTCQX Best Market for Better Investor Visibility TORONTO, May 1, 2019 /PRNewswire/ - Canntab Therapeutics Limited...


Apr 23, 2019, 08:30 ET Canntab Advances its Revenue Model with Recent Sales License Approval for FSD Pharma from Health Canada

- Opens the Door for Canadian and International Sales and White Labeling - TORONTO, April 23, 2019 /PRNewswire/ - Canntab Therapeutics Limited (CSE:...